Información del artículo
El Texto completo está disponible en PDF
Blbliografía
[1.]
J.P. Whisnant.
Modeling of risk factors for ischemia stroke: The Willis lecture.
Stroke, 28 (1997), pp. 1839-1843
[2.]
P.N. Hopkins, R.R. Williams.
Identification and relative weigth of cardiovascular risk factors.
Cardiol Clin, 4 (1986), pp. 3-31
[3.]
J. Stamler.
Established major coronary risk factors.
Coronary heart disease: From aetiology to public health,
[4.]
T.A. Pearson, V. Fuster.
Executive summary. 27th Bethesda Conference. Matchins the intensity of risk factors management with the hazard for coronary disease events.
J Am Coll Cardiol, (1996), pp. 961-963
[5.]
S.M. Grundy, R. Pasternak, P. Greenland, S. Smith Jr, V. Fuster.
Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology.
Circulation, 100 (1999), pp. 1481-1492
[6.]
Pinto X..
Hiperhomocisteinemia. Diagnóstico y tratamiento.
Clin Invest Arterioscler, 13 (2001), pp. 50-58
[7.]
P.M. Veland.
Homocysteine species as components of plasma redox thiol status.
Clin Chem, 41 (1995), pp. 340-342
[8.]
J.D. Finkelstein.
The metabolism of homocysteine: Pathways and regulation.
Eur J Pediatr, 157 (Suppl 2) (1998), pp. 40-44
[9.]
J.D. Finkelstein, J.J. Martin, B.K. Harry, W.E. Kyle.
Regulation of hepatic betaine-homcysteine methyltransferase by diatry betaine.
J Nutr, 113 (1983), pp. 519-521
Copyright © 2002. Asociación Española de Pediatría
